Igarashi M - Search Results

1

Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy.

Bertorini TE, Palmieri GM, Griffin JW, Igarashi M, McGee J, Brown R, Nutting DF, Hinton AB, Karas JG. Bertorini TE, et al. Among authors: igarashi m. Neurology. 1988 Apr;38(4):609-13. doi: 10.1212/wnl.38.4.609. Neurology. 1988. PMID: 3281058 Clinical Trial.

2

Congenital muscular dystrophy presenting with respiratory failure.

Dick M, Bertorini TE, Igarashi M. Dick M, et al. Among authors: igarashi m. Dev Med Child Neurol. 1992 Mar;34(3):262-5. doi: 10.1111/j.1469-8749.1992.tb15001.x. Dev Med Child Neurol. 1992. PMID: 1559607

3

Effect of dantrolene in Duchenne muscular dystrophy.

Bertorini TE, Palmieri GM, Griffin J, Igarashi M, Hinton A, Karas JG. Bertorini TE, et al. Among authors: igarashi m. Muscle Nerve. 1991 Jun;14(6):503-7. doi: 10.1002/mus.880140603. Muscle Nerve. 1991. PMID: 1852156 Clinical Trial.

4

Assessment of whole body composition with dual energy x-ray absorptiometry in Duchenne muscular dystrophy: correlation of lean body mass with muscle function.

Palmieri GM, Bertorini TE, Griffin JW, Igarashi M, Karas JG. Palmieri GM, et al. Among authors: igarashi m. Muscle Nerve. 1996 Jun;19(6):777-9. doi: 10.1002/(SICI)1097-4598(199606)19:6<777::AID-MUS15>3.0.CO;2-I. Muscle Nerve. 1996. PMID: 8609931 No abstract available.

5

Diltiazem in the treatment of calcinosis in juvenile dermatomyositis.

Bertorini TE, Sebes JI, Palmieri GM, Igarashi M, Horner LH. Bertorini TE, et al. Among authors: igarashi m. J Clin Neuromuscul Dis. 2001 Jun;2(4):191-3. doi: 10.1097/00131402-200106000-00005. J Clin Neuromuscul Dis. 2001. PMID: 19078635

6

Effects of 3-4 diaminopyridine (DAP) in motor neuron diseases.

Bertorini TE, Rashed H, Zeno M, Tolley EA, Igarashi M, Li YD. Bertorini TE, et al. Among authors: igarashi m. J Clin Neuromuscul Dis. 2011 Mar;12(3):129-37. doi: 10.1097/CND.0b013e3182095b2b. J Clin Neuromuscul Dis. 2011. PMID: 21321491 Clinical Trial.

7

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.

Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM; Cooperative International Neuromuscular Research Group. Pegoraro E, et al. Neurology. 2011 Jan 18;76(3):219-26. doi: 10.1212/WNL.0b013e318207afeb. Epub 2010 Dec 22. Neurology. 2011. PMID: 21178099 Free PMC article.

8

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, Tesi-Rocha C, Gorni K, Pasquali L, Patel KM, McCarter R, Huang J, Mayhew T, Bertorini T, Carlo J, Connolly AM, Clemens PR, Goemans N, Iannaccone ST, Igarashi M, Nevo Y, Pestronk A, Subramony SH, Vedanarayanan VV, Wessel H; CINRG Group. Escolar DM, et al. Among authors: igarashi m. Ann Neurol. 2005 Jul;58(1):151-5. doi: 10.1002/ana.20523. Ann Neurol. 2005. PMID: 15984021 Clinical Trial.

9

Comparative Long-Term Evaluation of Patients With Juvenile Inflammatory Myopathies.

Elahi HA, Bertorini TE, Igarashi M, Mays WH 3rd, Whitaker JN. Elahi HA, et al. Among authors: igarashi m. J Clin Neuromuscul Dis. 2016 Sep;18(1):21-7. doi: 10.1097/CND.0000000000000131. J Clin Neuromuscul Dis. 2016. PMID: 27552385

10

Postpoliomyelitis muscle pseudohypertrophy.

Bertorini TE, Igarashi M. Bertorini TE, et al. Among authors: igarashi m. Muscle Nerve. 1985 Oct;8(8):644-9. doi: 10.1002/mus.880080803. Muscle Nerve. 1985. PMID: 4058471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,892 results

Search Page

Filters